Adalimumab Kit
Product Images NDC 83257-021

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Adalimumab (NDC 83257-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Biologics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1. Study Ra-iii Acr 20 Responses Over 52 Weeks (Image 01)

Figure 1. Study Ra-iii Acr 20 Responses Over 52 Weeks (Image 01)
FDA Label Image

Figure 2. Asas 20 Response By Visit, Study As-i (Image 02)

Figure 2. Asas 20 Response By Visit, Study As-i (Image 02)
FDA Label Image

Hulio Pen Logo (Image 03)

Hulio Pen Logo (Image 03)
FDA Label Image

Pen Instructions For Use Figure A (Image 04)

Pen Instructions For Use Figure A (Image 04)
This text provides instructions for an Adalimumab Pen Injection. It mentions an Orange Indicator inside the barrel, a caution for the Orange Activator with a needle inside, and guidance not to uncap until you are ready to inject and won't be interrupted. It also includes details like the Fill Marker, Small Inner Gray Cap, and Protective Clear Cap.*
FDA Label Image

Pen Instructions For Use Figure B (Image 05)

Pen Instructions For Use Figure B (Image 05)
FDA Label Image

Pen Instructions For Use Figure C (Image 06)

Pen Instructions For Use Figure C (Image 06)
This text appears to contain information about a figure labeled "CE", a fill marker for medicine, and the presence of bubbles being normal.*
FDA Label Image

Pen Instructions For Use Figure D (Image 07)

Pen Instructions For Use Figure D (Image 07)
FDA Label Image

Pen Instructions For Use Figure E (Image 08)

Pen Instructions For Use Figure E (Image 08)
FDA Label Image

Pen Instructions For Use Figure F (Image 09)

Pen Instructions For Use Figure F (Image 09)
This is a "Squeeze Site" that can be used for evaluating the abdomen or thighs. This site may refer to a location where a person is instructed to squeeze or pinch for assessment purposes.*
FDA Label Image

Pen Instructions For Use Figure G (Image 10)

Pen Instructions For Use Figure G (Image 10)
FDA Label Image

Pen Instructions For Use Figure H (Image 11)

Pen Instructions For Use Figure H (Image 11)
FDA Label Image

Pen Instructions For Use Figure I (Image 12)

Pen Instructions For Use Figure I (Image 12)
FDA Label Image

Pen Instructions For Use Figure J (Image 13)

Pen Instructions For Use Figure J (Image 13)
FDA Label Image

Hulio Syringe Logo (Image 14)

Hulio Syringe Logo (Image 14)
FDA Label Image

Instructions For Use Figure A (Image 15)

Instructions For Use Figure A (Image 15)
This is a description of a medicine fill marker with instructions on when to uncap the needle cap and a needle safety feature that activates after the syringe is used. The text also mentions that the strength and expiration date shown may vary.*
FDA Label Image

Instructions For Use Figure B (Image 16)

Instructions For Use Figure B (Image 16)
FDA Label Image

Instructions For Use Figure C (Image 17)

Instructions For Use Figure C (Image 17)
This text appears to be discussing a fill marker used in medicine, mentioning the presence of bubbles as a normal occurrence.*
FDA Label Image

Instructions For Use Figure D (Image 18)

Instructions For Use Figure D (Image 18)
FDA Label Image

Instructions For Use Figure E (Image 19)

Instructions For Use Figure E (Image 19)
FDA Label Image

Instructions For Use Figure F (Image 20)

Instructions For Use Figure F (Image 20)
This description refers to a product or service related to websites focusing on managing weight, fitness, or wellness. It could be about exercises, diet plans, or products targeting the abdomen or thighs for toning or weight loss.*
FDA Label Image

Instructions For Use Figure G (Image 21)

Instructions For Use Figure G (Image 21)
FDA Label Image

Instructions For Use Figure H (Image 22)

Instructions For Use Figure H (Image 22)
FDA Label Image

Instructions For Use Figure I (Image 23)

Instructions For Use Figure I (Image 23)
FDA Label Image

Adalimumab-fkjp Prefilled Syringe Carton (20 mg/0.4 mL)

Adalimumab-fkjp Prefilled Syringe Carton (20 mg/0.4 mL)
FDA Label Image

Adalimumab-fkjp Prefilled Syringe Carton (40 mg/0.8 mL)

Adalimumab-fkjp Prefilled Syringe Carton (40 mg/0.8 mL)
FDA Label Image

Adalimumab-fkjp Prefilled Pen (40 mg/0.8 mL)

Adalimumab-fkjp Prefilled Pen (40 mg/0.8 mL)
This appears to be information related to a medication known as Adalimumab-fkjp Pen Injection, with the concentration of 40 mg/0.8 mL. The text provides details on subcutaneous use, storage instructions, composition of the solution, and specific handling guidance. It emphasizes using the pen within a certain timeframe after removal from the refrigerator and gives additional storage instructions for room temperature. The text contains directions for administration and crucial details to note, such as not using the medication beyond its expiration date. The product should be stored with protection from light and not frozen. Additionally, it mentions the importance of following the instructions on the pen label after removal from the refrigerator.*
FDA Label Image

Figure 3: Kaplan-meier Curves Summarizing Time To Treatment Failure On Or After Week 6 (study Uv I) Or Week 2 (study Uv Ii) (Image 27)

Figure 3: Kaplan-meier Curves Summarizing Time To Treatment Failure On Or After Week 6 (study Uv I) Or Week 2 (study Uv Ii) (Image 27)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.